DOCSLIB.ORG

Chestnut Hill College Department of Biology Biomedical Seminar Series

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Chestnut Hill College Department of Biology Biomedical Seminar Series Chestnut Hill College Department of Biology Biomedical Seminar Series Distinguished Speakers 1994 –2012 BIOmeDIcAL SemINAr SerIeS GOALS AND VISION v To provide a forum at Chestnut Hill College for learning Office of the President recent advances in biomedical research. Since 1994, Chestnut Hill College has been enhanced and broadened by the Biomedical To expose our students and faculty to prominent Seminar Series sponsored by the Biology Department. This series presents students with an v opportunity to meet, interact, listen, and learn from some of the most prestigious scientists in the scientific and medical professionals. country. Over the years, these encounters have opened the doors of research laboratories to our students to provide them with stellar internships and incomparable mentors. It is no exaggeration to say that through these encounters lives have been changed, careers launched, v To foster meaningful interactions and collaboration and horizons expanded. among our neighboring institutions. This program of lectures is genuinely unique; unique because, unlike similar series at large universities, it is neither endowed nor funded by an external source. On the contrary, prominent scientists spend a day of their precious time with Chestnut Hill students out of the To develop new contacts for all our students who are generous bounty of their hearts. Among them are Presidents of institutions, a Nobel Laureate, v Directors of Centers, Senior Administrators, elected members of the National Academy of interested in pursuing careers in biotechnology, basic Sciences, Department Chairpersons, Distinguished Scholars, and Lasker Award recipients. These women and men, who are among the best in their respective fields, exemplify for research, health and medicine. students the dedication and tenacity, the determination and perseverance, the innovation and creativity that underlie and vitalize scientific inquiry and research. To have them among the College Community even for a day is both an honor and a privilege. v To promote a new interest in the field of nanotechnology I would be remiss if I did not acknowledge the superlative contribution of Lakshmi and nanomedicine. Atchison, Ph.D., Professor of Biology in establishing and continuing to oversee this program. To consistently bring to campus, twice each year, women and men of the caliber of these lecturers is a phenomenal feat that requires not only an enormous commitment of time, but also a LAkShmI AtchISON , P h.D. dedication to the endeavor that is truly singular. All of us are indebted to Dr. Atchison for her work in founding a seminar series that sets Chestnut Hill College apart from its competitors Professor of Biology and offers to students in the sciences an opportunity to learn from some of the finest minds of Director of Biomedical Series our time. While we learn a great deal from textbooks and glean important lessons from experiments, nothing teaches us as well as the example of great teachers who are also great human beings. Chestnut Hill College students touch and are touched by such greatness through this incredibly valuable lecture series. In years to come, many of them will look back and marvel at the people who populated the stage of their undergraduate experience at this liberal arts College on two hills. Carol Jean Vale, SSJ, Ph.D. President 4LISt OF DIStINGuISheD SPeAkerS LISt OF DIStINGuISheD SPeAkerS 5 march 1994 carlo m. croce, m.D. 9 February 1997 marylin J. manco-Johnson, m.D. 23 Genetics of Human Cancer Perspectives on Hemophilia Research From the Gene to the Clinical Application April 1994 Anna m. Skalka, Ph.D. 10 Retroviral DNA Integration: October 1997 David kritchevsky, Ph.D. 24 Anatomy of a Hostile Takeover Diet and Atherosclerosis: Everything Counts April 1994 Alfred G. knudson, m.D., Ph.D. 11 April 1998 Alumna Stephanie A. king, m.D. 25 The Human Cancer Gene Diagnosis and Treatment of Gynecological Malignancies October 1994 robert P. Perry, Ph.D. 12 Regulation of Ribosome Biosynthesis November 1998 robert F. Ozols, m.D., Ph.D. 26 The Biology and Treatment of Ovarian Cancer November 1994 e. Premkumar reddy, Ph.D. 13 “Myb” Gene Family: Structure and Function April 1999 Vincent J. cristofalo, Ph.D. 27 Journeys in Cellular Aging February 1995 kay huebner, Ph.D. 14 Kidney Tumor Suppressor Genes October 1999 Peter c. Nowell, m.D. 28 Cancer Research: Promise and Paradox April 1995 James Wilson, m.D., Ph.D. 15 The Prospects for Human Gene Therapy April 2000 michael L. Atchison, Ph.D. 29 Genetic Testing for Diseases: April 1995 robert L. comis, m.D. 16 A Judeo-Christian Perspective The Biology of Lung Cancer October 2000 robert c. Young, m.D. 30 October 1995 timothy r. tomlinson 17 Cancer Medicine in the 21st Century Botanic Gardens and Contemporary Research in Plants as Medicine April 2001 mary B. Daly, m.D., Ph.D. 31 Breast Cancer: Moving Toward Prevention October 1995 rick Lewandowsky 18 Botanic Gardens and Contemporary Research October 2001 thomas W. London, m.D. 32 in Plants as Medicine The Global Health Crisis November 1995 Shirley m. tilghman, Ph.D. 19 February 2002 Paul F. engstrom, m.D. 33 The Importance of Genomic Imprinting for Cancer Chemoprevention: Is it Ready for Prime Time? Mammalian Growth and Development April 2002 kelly A. robinson, m.D., F.A.A.e.m. 34 November 1995 Beverly S. emanuel, Ph.D. 20 Emergency Treatment of Cerebrovascular Human Genome Initiative: Chromosome 22 Accidents and Other New Medical Procedures as a Model march 2003 michael J. Behe, Ph.D. 35 April 1996 Alan m. kelly, B.V.Sc., m.r.c.V.S., Ph.D. 21 Evidence of Design in Biochemistry The Opportunities for the Veterinarian in Basic October 2003 robert L. Quigley, m.D., Ph.D., F.A.c.S. 36 Research and in Clinical Medicine How Do You Mend a Broken Heart? October 1996 Arthur c. upton, m.D. 22 march 2004 Letter from William t. Walker, Ph.D. 37 Radiation, Genes and Cancer, Former Vice President for Academic Affairs and Issues in Risk Assessment Dean of the Faculty 6LISt OF DIStINGuISheD SPeAkerS LISt OF DIStINGuISheD SPeAkerS 7 march 2004 Stanley B. Prusiner, m.D. 38 October 2010 thomas W. Yun, m.D. 51 The Mad Cows That Changed America Medicine in the Foreign Service November 2004 eric Lee Vey, m.D. 39 April 2011 Anthony P. Green, Ph.D. 52 Forensic Pathology: A “Dead” Science The Nanotechnology Institute: Accelerating Innovation and Entrepreneurship Through April 2005 marcia Boraas, m.D. 40 Technology Commercialization Evolution of Breast Surgery September 2011 michael V. Seiden, m.D., Ph.D. 53 November 2005 Gary Smith, m.A., m.S., D.Phil. 41 The Evolution of Cancer Care: Foot and Mouth Disease: Catastrophic Infectious Past, Present and Future Disease Epidemics in Domesticated Animals February 2012 Dawn Bonnell, Ph.D. 54 April 2006 Joan c. hendricks, VmD, Ph.D. 42 Probing BioSystems at the Nanoscale Lessons From Many Species About How and Why We Sleep Lakshmi Atchison, Ph.D. 55 October 2006 carole muto, r.N., B.S.N., c.P.A.N. 43 Professor of Biology, chestnut hill college Perioperative Nursing Care of Patients Undergoing Director of Biomedical Series Neurosurgical Procedure march 2007 richard D. Lackman, m.D., F.A.c.S. 44 Design Evolution in Orthopedic Devices September 2007 Sheldon L. Gerstenfeld, VmD 45 How to Balance Your Life for Physical and Mental Health:A Veterinarian’s Journey April 2008 Dean W. richardson, VmD, Ph.D. 46 Mechanical and Biological Challenges in Equine Orthopedics September 2008 Alumna Anna c. O’riordan, m.D. 47 Pediatric Cardiology 1960–2008 march 2009 randall W. culp, m.D. 48 Hand Surgery Challenges in 2009 October 2009 c. Lowell Parsons, m.D. 49 From Basic Laboratory Research to the Patient: One Physician’s Search for Answers to Bladder Disease April 2010 Alumna mary e. Brandt, Ph.D. 50 The Fungus Among Us: An Introduction to Public Health Mycology cArLO m. c rOce , m.D. 9 march 1994 Opening Speaker carlo m. croce, m.D. Director, kimmel cancer center kimmel cancer Institute thomas Jefferson university Kenneth J. Soprano, Ph.D. elected to the National Academy of Sciences, 1996 VICE PRESIDENT FOR ACADEMIC AFFAIRS and DEAN OF THE FACULTY title: Genetics of human cancer Chestnut Hill College is a small, Catholic, liberal arts college which takes pride in offering its students many opportunities to learn both inside and outside the classroom. Dr. carlo croce is Director of the Kimmel Cancer Institute As such it is not unusual for our students, like those at many other small liberal arts colleges, to be exposed to a wide range of opportunities such as guest lectures, panel and Kimmel Cancer Center at the Thomas Jefferson discussions by external speakers, performances, and symposiums. It is rare, however, University in Philadelphia, Pennsylvania and has held this for students at an institution such as ours to have the privilege of meeting and position since 1991. During this same time Dr. Croce has interacting with the number and type of distinguished scientists that the Biomedical Lecture Series has brought to campus. Included in the list of 43 speakers who have been Professor and Chairman of the Department of participated in this series is a Nobel Prize in Medicine winner, six members elected to Microbiology/Immunology at Thomas Jefferson University. the National Academy of Sciences, two Lasker Award winners, a Benjamin Franklin Dr. Croce has been a member of the CorCell Scientific and Medal in Life Sciences winner and a General Motors Cancer Research Foundation Medical Advisory Committee since 1996 serving as its first awardee. Our students have also heard lectures from a variety of Deans, Section Chiefs, Department Chairs and Institute Presidents, Vice Presidents and Directors.
Load more

Recommended publications
  • 158273436.Pdf
    4. , .;z.. ", ,:,. - 21sk , 44 "00,4 'WM 4 44 44 4 COLD SPRING HARBOR LABORATORY OF QUANTITATIVE BIOLOGY ESTABLISHED JULY 1, 1963 ANNUAL REPORT 1967 COLD SPRING HARBOR, LONG ISLAND, NEW YORK COLD SPRING HARBOR LABORATORY OF QUANTITATIVE BIOLOGY COLD SPRING HARBOR, LONG ISLAND,NEW YORK OFFICERS OF THE CORPORATION Chairman: Dr. H. Bentley Glass Secretary: Dr. Harry G. Albaum 1st Vice-Chairman: Mr. Walter H. Page Treasurer: Mr. Richard B. McAdoo 2nd Vice-Chairman: Assistant Secretary-Treasurer Dr. James D. Watson Mr. John B. Philips Laboratory Director: Dr. John Cairns BOARD OF TRUSTEES AND PARTICIPATING INSTITUTIONS Rockefeller University Albert Einstein College of Medicine Dr. Norton Zinder Dr. Harry Eagle Long Island Biological Association Duke University Mr. Walter H. Page Dr. Samson Gross Princeton University Brooklyn College of the City University of Dr. Arthur B. Pardee New York Dr. Harry G. Albaum New York University Medical Center The Public Health Research Institute of New York University of the City of New York, Inc. Dr. Alan W. Bernheimer Dr. Paul Margolin Sloan-Kettering Institute for Cancer Research Dr. Leo Wade INDIVIDUAL TRUSTEES Dr. H. Bentley Glass Mr. Richard B. McAdoo Dr. I. C. Gunsalus Dr. Lewis Sarett Dr. Alexander Hollaender Mr. Dudley W. Stoddard Dr. James D. Watson TABLE OF CONTENTS Board of Trustees 2 Director's Report 5-7 Year-round Research Activities 8-15 32nd Cold Spring Harbor Symposium "Antibodies" 16-17 Phycomyces Workshop 18-19 Summer Post-Graduate Training Courses 20-22 Undergraduate Research Participation
    [Show full text]
  • 2013 Highlights the Center for Retrovirus Research 2013 Distinguished Research Career Award Dr
    Newsletter of the Center for Retrovirus Research at The Ohio State University College of Veterinary Medicine 2013 Highlights The Center for Retrovirus Research 2013 Distinguished Research Career Award Dr. Anna Marie (Ann) Skalka PhD. Professor and W. W. Smith Chair in Cancer Research, Senior Advisor to the President, Fox Chase Cancer Center, Philadelphia, PA was the 14th recipient of the annual award for her seminal contributions to our understanding of the biochemical mechanisms by which retroviruses (including HIV) replicate and insert their genetic material into the host genome. Dr. Anna Marie Skalka of this protein as well as exploiting it as a therapeutic (center) receives Career target. Dr. Skalka has published more than 240 scientific Award crystal from Center for Retrovirus Research papers and scholarly reviews, has edited several Director Dr. Patrick L. Green scientific books, organized and spoken at national and (right) and Center member international meetings and conferences, and is coauthor Dr. Mamuka Kvaratskhelia of the widely acclaimed textbook, Principles of Virology. (left). Distinguished award lecture entitled Dr. Skalka has served on the editorial boards of several “Deciphering the Anatomy peer-reviewed scientific journals and has been a member of a DNA Invasion Machine: of numerous advisory boards, including the National the Retroviral Integrases”. Cancer Institute Board of Scientific Counselors, the Dr. Skalka obtained her Ph.D. degree in Microbiology General Motors Cancer Research Foundation Awards from New York University Medical School with Dr. Jerard Assembly, the Board of Governors of the American Hurwitz, and was a postdoctoral fellow with Nobel Academy of Microbiology, and the National Advisory Laureate, Dr.
    [Show full text]
  • Celebrating Years
    Chestnut Hill College Department of Biology Celebrating Biomedical Lecture Series 20 Distinguished Speakers Years 1994 – 2013 Keynote Speaker Keynote Speaker 10th Anniversary 20th Anniversary March 2004 September 2013 Stanley B. Prusiner, M.D. Michael S. Brown, M.D. Nobel Prize for Medicine Nobel Prize for Medicine or Physiology or Physiology ii GOALS AND VISION Of the BIOmeDIcAL Lecture SerIeS GOALS AND VISION v To provide a forum at Chestnut Hill College for learning Office of the President recent advances in biomedical research. Since 1994, Chestnut Hill College has been enhanced and broadened by the Biomedical To expose our students and faculty to prominent Seminar Series sponsored by the Biology Department. This series presents students with an v opportunity to meet, interact, listen, and learn from some of the most prestigious scientists in the scientific and medical professionals. country. Over the years, these encounters have opened the doors of research laboratories to our students to provide them with stellar internships and incomparable mentors. It is no exaggeration to say that through these encounters lives have been changed, careers launched, v To foster meaningful interactions and collaboration and horizons expanded. among our neighboring institutions. This program of lectures is genuinely unique; unique because, unlike similar series at large universities, it is neither endowed nor funded by an external source. On the contrary, prominent scientists spend a day of their precious time with Chestnut Hill students out of the To develop new contacts for all our students who are generous bounty of their hearts. Among them are Presidents of institutions, two Nobel v Laureates, Directors of Centers, Senior Administrators, elected members of the National interested in pursuing careers in biotechnology, basic Academy of Sciences, Department Chairpersons, Distinguished Scholars, and Lasker Award recipients.
    [Show full text]
  • Cancer Research 2007.Pdf
    r i a h Dear Governor Corzine: C We who serve on the New Jersey Commission on Cancer Research (NJCCR) thank you most sincerely for your continued support of our activities. This 2007 Annual Report summarizes key accomplishments and e research highlights from a wide range of science supported by our program. h t Throughout this report, you will see evidence of our continued efforts to identify, solicit, and support high quality, innovative research that will have a significant impact on cancer in New Jersey, as well as our commitment to ensure that this research is disseminated and m translated in the health care and public health arenas. o Of greatest significance in 2007 were the exciting results from a 15 month intensive and independent r evaluation of the NJCCR programs that was conducted by members of the Bloustein School of f Urban Policy & Planning at Rutgers, The State University. The NJCCR commissioned this rigorous self-assessment to measure its efficiency and effectiveness based on quantifiable data. It is our pleasure to report that the positive outcomes of NJCCR strategies to promote original and e significant cancer research in New Jersey exceeded our expectations in all categories. g For example, the NJCCR’s open and fair system of Seed Grant awards provides proven benefits to a scientists and research institutions throughout the state by: leveraging $10.44 back to New Jersey for every state dollar spent; stimulating new ideas and research directions and opening doors to national s recognition. Increased funding for state research institutions is also expanded through the indirect costs included in these awards.
    [Show full text]
  • Retroviral Protease (Retroviruses/Avian Sarcoma4eukosis Virus/Human Immunodeficiency Virus) MOSHE KOTLER*T, RICHARD A
    Proc. Natl. Acad. Sci. USA Vol. 85, pp. 4185-4189, June 1988 Biochemistry Synthetic peptides as substrates and inhibitors of a retroviral protease (retroviruses/avian sarcoma4eukosis virus/human immunodeficiency virus) MOSHE KOTLER*t, RICHARD A. KATZ*t, WALEED DANHO§, JONATHAN LEIs¶, AND ANNA MARIE SKALKA*tII *Department of Molecular Oncology, Roche Institute of Molecular Biology and §Peptide Research Department, Hoffmann-La Roche, Inc., Roche Research Center, Nutley, NJ 07110; and $Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106 Communicated by Sidney Udenfriend, February 16, 1988 ABSTRACT Processing of the gag and pol gene precursor The results presented here show that a decapeptide com- proteins of retroviruses is essential for infectivity and is posed of the cleavage site between the a and pp32 domains directed by a viral protease that is itself included in one ofthese of the ASLV reverse transcriptase-integration polyprotein precursors. We demonstrate here that small synthetic peptides (pol) can be cleaved at the expected site by PR. Changes in can be used as both model substrates and inhibitors to the amino acids that flank the cleavage site ofthe peptide (and investigate the specificity and molecular parameters of the of the larger pol precursor) alter the capacity of the peptides reaction. The results indicate that a peptide that extends five to serve as substrates. Some peptides that are not cleaved act amino acids but not three amino acids in both directions from as inhibitors of PR. a known cleavage site is accurately hydrolyzed by the protease of avian sarcoma-leukosis virus. Substitutions of the amino MATERIALS AND METHODS acids to either side of the peptide bond to be cleaved affect the ability of the peptide (as well as a larger precursor protein) to PR Digestion of pol Precursor Proteins Synthesized in serve as a substrate.
    [Show full text]
  • Fox Chase Cancer Center Forward, Winter/Spring 2020
    BROADENING THE CONVERSATION ABOUT CANCER | WINTER/SPRING 2020 SHATTERING THE GLASS BEAKER Women Past and Present Have Played Key Roles at Fox Chase G43051_Forward Magazine.indb 1 2/25/20 10:16 AM FORWARD THINKING PRESIDENT’S MESSAGE MAKING THE UNCOMMON COMMON or many of us, cancer is Chase a culture and a leader who something familiar. It has helped fuel their drive to contrib- touched us in some way, ute meaningfully to our under- whether personally, in our standing of cancer and to achieve families, or amongst our greatness through their own career Ffriends or colleagues. One might accomplishments. consider it a common thing, but to With the help of new drugs face it takes uncommon strength called immune checkpoint inhib- and exceptional insight. itors, we are seeing success treat- Fox Chase Cancer Center is a ing patients in ways we haven’t be- place where uncommon things fore. In these pages, we share how happen. Within our institution ongoing research is increasing our are people who are extraordi- knowledge of the complexities of nary—patients who carry on the human immune system and boldly through the seemingly im- how to harness its power to kill donors, and the entire Fox Chase possible and clinicians, scientists, cancer. In some cases, the positive family, and we look forward to and sta who do the exceptional to eects of immune checkpoint in- new collaborations on the hori- help them prevail. hibitor drugs last months to years. zon that will help us get closer to Our cover story in this issue There is still much work to do.
    [Show full text]
  • 2019 Highlights
    Highlights of the Year Research Hundreds of scientists working in Cold Spring Harbor Laboratory’s 50-plus laboratory groups contributed to research that in 2019 was published in the world’s major research journals. Their efforts reflect the full spectrum of this institution’s scientific activity in cancer, neuroscience, plant biology, quantitative biology, and genomics. The following is a sampling of this year’s important findings. Machine Learning Better Interprets Gene Regulation Machine learning algorithms are helping biologists make sense of molecular signals that control how genes function, but algorithms developed to analyze larger and larger sets of data become increasingly complex and difficult to interpret. Associate Professor Justin B. Kinney has an approach to design advanced machine learning algorithms that are easier for biologists to understand. The algorithms are a type of artificial neural network (ANN). Inspired by the way neurons connect and branch in the brain, ANNs are the computational foundations for advanced machine learning. Biologists use ANNs to analyze data from an experimental method called a “massively parallel reporter assay” (MPRA), which investigates DNA. Using this data, quantitative biologists can make ANNs that predict which molecules J. Kinney control specific genes in a process called gene regulation. Unfortunately, the way standard ANNs are shaped from MPRA data is very different from how scientists ask questions in the life sciences. Kinney’s approach bridges this gap between computational tools and how biologists think. These custom ANNs mathematically reflect common concepts in biology concerning genes and the molecules that control them, forcing data to be processed in a way that a biologist can understand.
    [Show full text]
  • New Jersey Commission on Cancer Research
    New Jersey Commission on Cancer Research 2018-19 Annual Report Dedicated to conquering cancer through scientific research C2780 A Message from the Chair Dear Governor Murphy: r i s Chairperson of the New Jersey Commission on Cancer a Research and on behalf of our Commissioners, it gives me great pleasure to report on our activities over the past two h years for 2018 and 2019. A C In our 36-year history since the NJCCR was formed, by the NJ State Legislature, we have awarded more than $45 million for e over 900 peer reviewed cancer research grants and student fellowships. Our grantees have leveraged a return of over $10 in h federal research funding for every NJCCR dollar awarded for t over a total of $455 million. These grants have been awarded to the Cancer Institute of New Jersey, Rutgers University both in Newark and Piscataway, Princeton University, Rutgers School of Dental Medicine, Cooper Medical School at Rowan University m and to the Center for Discovery and Innovation at Hackensack o Medical Center. r These funds can be used for basic cancer science research, f including research for breast, lung, colon and prostate cancer. We have instituted our Annual Fall Cancer Research Symposium e where, for the past two years, we have had greater than 60 poster presentations by the grantees presenting their research findings. g At this event, we had a panel discussion on post-fellowship a employment opportunities by members of the New Jersey Commission on Cancer Research to help grantees find positions s after they have completed their research work.
    [Show full text]
  • The New Jersey Breast and Prostate Cancer Research Funds
    The New Jersey Commission on Cancer Research (NJCCR) promotes significant and original research in New Jersey into the causes, prevention and treatment of cancer and serves as a resource to providers and consumers of cancer services. Inside Message from the Chair.........................................................1 Our History and Approach...................................................3 NJCCR Members and Staff...................................................5 2005 - The Year’s Highlights................................................11 Research and Grant Highlights............................................17 Fellowships: A Commitment to the Future..........................21 Financial Summary.............................................................23 Advisory Group Members...................................................25 A Message from the Chair Dear Governor Corzine: On behalf of the State of New Jersey Commission on Cancer Research (NJCCR) we are pleased and proud to present our 2005 Annual Report. The NJCCR is a unique state agency which was formed in 1983 to launch a bold new attack on cancer. It has done this through the funding of research into the causes and treatment of cancer. This research has been conducted by promising young New Jersey scientists working in our academic institutions and hospitals. Through its system of peer review, utilizing the talents of some of our nation's leading scientists, we have funded over $27.6 million for 627 research projects on cancer over the past 20 years. However, this represents only a fraction of the total number of projects reviewed and approved, for which funding was not available. The NJCCR’s competitive seed grant program continues to gain national recognition as a model to effectively leverage major grants from national funding sources and has generated $5.65 in national research monies for every dollar awarded in seed grants (2004).
    [Show full text]
  • JOURNAL of VIROLOGY VOLUME 61 * DECEMBER 1987 * NUMBER 12 Arnold J
    JOURNAL OF VIROLOGY VOLUME 61 * DECEMBER 1987 * NUMBER 12 Arnold J. Levine, Editor in Chief Thomas E. Shenk, Editor (1989) (1989) Princeton University Princeton University Princeton, N.J. Princeton, N.J. Anna Marie Skalka, Editor (1989) Bernard N. Fields, Editor (1988) Fox Chase Cancer Center Harvard Medical School Philadelphia, Pa. Boston, Mass. George F. Vande Woude, Editor (1992) Robert A. Lamb, Editor (1992) NCI-Frederick Cancer Research Facility Northwestern University Frederick, Md. Evanston, Ill. Robert A. Weisberg, Editor (1988) Michael B. A. Oldstone, Editor (1988) National Institute of Child Health Scripps Clinic & Research Foundation and Human Development La Jolla, Calif. Bethesda, Md. EDITORIAL BOARD James Alwine (1988) Walter Gerhard (1989) Warren Masker (1987) Joseph Sambrook (1988) David Baltimore (1987) Joseph C. Glorioso (1989) Thomas Merigan (1989) Charles E. Samuel (1989) Tamar Ben-Porat (1987) Stephen P. Goff (1988) George Miller (1987) Priscilla A. Schaffer (1987) Kenneth I. Berns (1988) Larry M. Gold (1988) Lois K. Miller (1988) Sondra Schlesinger (1989) Michael Botchan (1989) Hidesaburo Hanafusa (1989) Peter Model (1989) Manfred Schubert (1988) Thomas J. Braciale (1988) John Hassell (1989) Bernard Moss (1989) Bart Sefton (1988) Joan Brugge (1988) William i. Hayward (1987) Opendra Narayan (1988) Bert L. Semler (1989) Michael J. Buchmeier (1989) Roger Hendrix (1987) Joseph R. Nevins (1988) Charles J. Sherr (1987) Barrie J. Carter (1987) John J. Holland (1987) Erling Norrby (1989) Saul J. Silverstein (1988) John M. Coffin (1989) Nancy Hopkins (1989) Nancy G. Nossal (1987) Patricia G. Spear (1987) Charles N. Cole (1989) Peter M. Howley (1987) Dennis O'Callaghan (1989) Bruce Stillman (1988) Geoffrey M.
    [Show full text]